A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis

2000; Oxford University Press; Volume: 39; Issue: 3 Linguagem: Inglês

10.1093/rheumatology/39.3.316

ISSN

1460-2172

Autores

T Lerndal,

Tópico(s)

Autoimmune and Inflammatory Disorders Research

Resumo

Objectives. The objectives of this study were to evaluate the therapeutic efficacy of CPH 82 in comparison with methotrexate (MTX) in adult patients with early, active rheumatoid arthritis (RA) and to compare the tolerance and safety profiles of the two drugs.

Referência(s)